​
​

Agile Therapeutics (AGRX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Agile Therapeutics Revenue Highlights

Latest Revenue (Y)

$19.59M

Latest Revenue (Q)

$5.58M

Agile Therapeutics Revenue by Period

Agile Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$19.59M80.02%
2022-12-31$10.88M165.40%
2021-12-31$4.10M447.53%
2020-12-31$749.00K100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--

Agile Therapeutics generated $19.59M in revenue during NA 2023, up 80.02% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Agile Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$5.58M-2.45%
2024-03-31$5.72M58.16%
2023-12-31$3.61M-45.75%
2023-09-30$6.66M21.06%
2023-06-30$5.50M44.32%
2023-03-31$3.81M-4.58%
2022-12-31$4.00M33.11%
2022-09-30$3.00M41.20%
2022-06-30$2.13M20.73%
2022-03-31$1.76M16.31%
2021-12-31$1.51M17.64%
2021-09-30$1.29M8.61%
2021-06-30$1.19M921.55%
2021-03-31$116.00K-84.51%
2020-12-31$749.00K100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Agile Therapeutics generated $5.58M in revenue during Q2 2024, up -2.45% compared to the previous quarter, and up 146.24% compared to the same period a year ago.

Agile Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.42M
AMRXAmneal Pharmaceuticals$2.39B$702.47M
ASRTAssertio$152.07M$29.20M
LFCRLifecore Biomedical$128.26M$24.70M
AQSTAquestive Therapeutics$50.58M$13.54M
CPIXCumberland Pharmaceuticals$39.55M$9.09M
TKNOAlpha Teknova$36.68M$9.58M
AGRXAgile Therapeutics$19.59M$5.58M
GHSIGuardion Health Sciences$12.25M$36.35K
EVOKEvoke Pharma$5.18M$2.65M
CYTHCyclo Therapeutics$1.08M$123.10K
ACRXTalphera$651.00K$117.00K
SHPHShuttle Pharmaceuticals--
PRFXPainReform--

AGRX Revenue FAQ

What is Agile Therapeutics’s yearly revenue?

Agile Therapeutics's yearly revenue for 2023 was $19.59M, representing an increase of 80.02% compared to 2022. The company's yearly revenue for 2022 was $10.88M, representing an increase of 165.40% compared to 2021. AGRX's yearly revenue for 2021 was $4.1M, representing an increase of 447.53% compared to 2020.

What is Agile Therapeutics’s quarterly revenue?

Agile Therapeutics's quarterly revenue for Q2 2024 was $5.58M, a -2.45% decrease from the previous quarter (Q1 2024), and a 1.33% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $5.72M, a 58.16% increase from the previous quarter (Q4 2023), and a 49.91% increase year-over-year (Q1 2023). AGRX's quarterly revenue for Q4 2023 was $3.61M, a -45.75% decrease from the previous quarter (Q3 2023), and a -9.56% decrease year-over-year (Q4 2022).

What is Agile Therapeutics’s revenue growth rate?

Agile Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 377.76%, and for the last 5 years (2019-2023) was 0%.